The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.


Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Challenges and hopes in treating interstitial lung disease in children

Imagine a world where breathing is a luxury and a cough marks the sound of an inner battle. Interstitial lung disease (ILD), a condition characterized by inflammation and fibrosis, is a major cause of severe respiratory illness ...

page 1 from 31